Assessment of multiple intrauterine gestations from ovarian stimulation AMIGOS trial Baseline characteristics

Monday, March 30, 2015
The baseline characteristics are provided for women with unexplained infertility who participated in the AMIGOS trial examining ovarian stimulation with gonadotropins, CC, and letrozole.

Read More

Aromatase inhibitors for subfertile women with polycystic ovary syndrome Summary of a Cochrane review

Friday, January 30, 2015
Letrozole appears to be superior to clomiphene citrate for ovulation induction in subfertile women with polycystic ovary syndrome.

Read More

Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons

Friday, March 1, 2013
Suppression of aromatase cytochrome P450 may inhibit the in vivo growth of endometriosis lesions in baboons.

Read More

Aromatase Inhibitors for the Treatment of Endometriosis

Thursday, November 29, 2012
A review is presented of the role of aromatase in the pathogenesis of endometriosis, discuss the pharmacology of aromatase inhibitors, and examine clinical applications of aromatase inhibitors for endometriosis treatment.

Read More

A historical perspective of aromatase inhibitors for ovulation induction

Thursday, November 29, 2012
This review provides a brief history of the development of letrozole for ovulation induction.

Read More

Ovarian stimulation and fertility preservation using aromatase inhibitors in women with breast cancer

Thursday, November 29, 2012
Studies suggest that in the short term, an aromatase inhibitor plus gonadotropin protocol is effective for safely inducing controlled ovarian hyperstimulation in women with breast cancer for fertility preservation.

Read More

Aromatase inhibitors for male infertility

Thursday, November 29, 2012
Aromatase inhibitors increase serum testosterone levels and can improve sperm production for infertile men with low serum testosterone and increased testosterone/estradiol ratios.

Read More

The use of aromatase inhibitors in in vitro fertilization

Thursday, November 29, 2012
The use of aromatase inhibitors in IVF patients is promising. Poor responders and patients at risk of ovarian hyperstimulation syndrome or high estrogen levels may benefit.

Read More

Changes in the hormonal profile and seminal parameters with the use of aromatase inhibitors in the management of infertile men with low testosterone to estradiol ratios

Wednesday, June 6, 2012
Therapy with 2.5 mg letrozole or 1 mg anastrazole daily, in cases of infertile men with low T/E2 ratios, leads to a significant increase of T/E2 ratio, ejaculate volume, sperm motility, and total motile sperm count.

Read More

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B

Friday, May 4, 2012
This report describes the peripheral levels of inhibin B and antimullerian hormone in boys during peripuberty and in patients with congenital hypogonadotropic hypogonadism.

Read More

Translate »